D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
INO holding history
Inovio Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
INO overviewAll 13F holders of INOFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,351,656
- Value
- $1.49M
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,351,656 | $1.49M | <0.1% | −861,163−38.9% | Reduced | Holders |
| Q1 2026 | 2,212,819 | $3.85M | <0.1% | −18,992−0.9% | Reduced | Holders |
| Q4 2025 | 2,231,811 | $3.88M | <0.1% | +1,425,069+176.6% | Added | Holders |
| Q3 2025 | 806,742 | $1.89M | <0.1% | +806,742 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −225,097−100.0% | Sold outConverted for a 1-for-12 split | Holders |
| Q4 2023 | 2,701,162 | $1.38M | <0.1% | −2,817,675−51.1% | Reduced | Holders |
| Q3 2023 | 5,518,837 | $2.15M | <0.1% | −2,083,296−27.4% | Reduced | Holders |
| Q2 2023 | 7,602,133 | $3.39M | <0.1% | +983,289+14.9% | Added | Holders |
| Q1 2023 | 6,618,844 | $5.43M | <0.1% | −1,851,856−21.9% | Reduced | Holders |
| Q4 2022 | 8,470,700 | $13.2M | <0.1% | +919,851+12.2% | Added | Holders |
| Q3 2022 | 7,550,849 | $13.0M | <0.1% | +1,552,599+25.9% | Added | Holders |
| Q2 2022 | 5,998,250 | $10.4M | <0.1% | +498,427+9.1% | Added | Holders |
| Q1 2022 | 5,499,823 | $19.7M | <0.1% | −485,710−8.1% | Reduced | Holders |
| Q4 2021 | 5,985,533 | $29.9M | <0.1% | +2,192,676+57.8% | Added | Holders |
| Q3 2021 | 3,792,857 | $27.2M | <0.1% | +1,702,996+81.5% | Added | Holders |
| Q2 2021 | 2,089,861 | $19.4M | <0.1% | +1,177,458+129.1% | Added | Holders |
| Q1 2021 | 912,403 | $8.47M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.